As a result, we now find a marginally significant difference in IgM antibody level growth rates and peak level timing between mild and severe cases.
← all excerpts
Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset.
1
—
—